Transaction Date
June 2025
Industry
Healthcare & Life Sciences
Target Company
Azzur Consulting
Buyer/Investor
Eliquent
Client Description
Azzur Consulting, a partner to leading pharmaceutical, biotechnology, and medical device manufacturers to provide efficient and innovative solutions that help them start, scale, and sustain their GxP organizations, was acquired by ELIQUENT Life Sciences, a portfolio company of GHO Capital. The transaction closed on May 6, 2025 (post-petition).